Dandruff
Conditions
Keywords
dandruff, treatment satisfaction
Brief summary
The aim of this study is to evaluate the satisfaction / tolerance / cosmeticity of Dercos DS
Interventions
OTHERDermocosmetic product: Selenium Disluphide Shampoo (Dercos DS)
to assess the benefit of Dercos DS in subjects with dandruff
Sponsors
Cosmetique Active International
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
12 Years to No maximum
Inclusion criteria
* Patients with dandruff or seborrheic dermatitis * All hair types * All ethnicities (Asian, Caucasian, Afro-American, African, Hispanic) * Including patients with specific occlusion habits (for instance veil use at least 8 hours per day, hat use) * Patients willing to provide written informed consent
Exclusion criteria
* Under 12 years old * Pregnancy, breast feeding, childbearing potential without adequate contraception, or irregular menstrual cycles. * History of allergy, anaphylaxis or hypersensitivity to any of the ingredients of Shampoo any of the ingredients of DERCOS ANTI-DANDRUFF normal to oily hair shampoo * History of allergic contact dermatitis secondary to shampoo, conditioner, mask, and/or leave-in. * Has any clinical manifestations in the treatment(s) or other disorders that, in the opinion of the investigator, may affect the evaluations or results of the study products.- Inability to stay the study period (56 days +-5 days) without performing any hair/scalp procedure, including coloring, straightening and cutting. * Inability to attend all study visits and follow treatment regimen
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Desquamation | Baseline | Scale (0=absence to 4= very severe) |
| Irritation | baseline | Scale (0=absence to 4= very severe) |
| Erythema | baseline | Scale (0=absence to 4= very severe) |
| Itching | baseline | Scale (0=absence to 10= very severe) |
| Area involved | baseline | scale from \<10% to \>90% |
| Tolerance | baseline | scale from 0= none to 5=very tolerated |
| Improvement | Day 28 | scale from 0= worse to 5=very clearly improved |
| Impact of dandruff on patient | baseline | Scale from 0=not bothered at all to 5=very bothered |
| Global evaluation by investigator | Day 28 | Scale from 0=not at all satisfactory at all to 4=very satisfactory |
| Assessment of hair fiber and quality | Day 56 | scale from 0=worsened to 4=very improved |
| Product respect/protects hair fiber | Day 56 | scale from 0=no, it is now more damaged/dry than before the treatment to 3=Yes, my hair fiber looks/feels better than before the treatment |
| Patient product efficacy satisfaction | Day 28 | questionnare with scale ranging from 0=completely disagree to 5=completely agree |
| Patient product acceptability | Day 28 | scale ranging from 0=not satisfied at all to 10=very satisfied |
| Patient global satisfaction | Day 28 | scale ranging from 0=not satisfied at all to 10=very satisfied |
Countries
Poland
Outcome results
None listed